Toxoplasma sporozoite genes that determine environmental resistance and invasion of host cells.

弓形虫子孢子基因决定宿主细胞的环境抵抗力和入侵。

基本信息

  • 批准号:
    10628015
  • 负责人:
  • 金额:
    $ 18.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-24 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary The parasite Toxoplasma gondii can cause severe disease in immunocompromised patients and fetuses and is the second leading cause of foodborne deaths in the USA. Infection starts after ingestion of oocysts shed in cat feces or after ingestion of meat contaminated with tissue cysts. Oocysts are extremely stable in the environment, resistant to the most inactivation procedures, and highly infectious. Because livestock get infected by sporozoites derived from oocysts, a vaccine based on sporozoites or sporozoite proteins could be effective in protecting livestock and humans. Currently, the only vaccine available is a live attenuated vaccine only approved for use in sheep. However, this vaccine has serious shortcomings as the genetic basis for the attenuation is not known, which poses reversion risks, and it needs to be used immediately once produced because it is based on live tachyzoites, which are not viable for long outside host cells. Despite being a critical step for Toxoplasma transmission, sporozoites inside oocysts are under-studied, largely because they are not cultivatable in vitro and difficult to access in vivo. There is, therefore, a critical need to identify sporozoite gene products that are critical for its invasion of host cells, which could lead to the discovery of vaccine targets. Furthermore, if the genetic basis for the extreme environmental resistance of sporozoites was known it might be possible to exploit this to make other Toxoplasma life stages, such as tachyzoites, or other pathogens more viable extracellularly, which could enhance the shelf-life of vaccines based on live parasites. Our overall objectives are to identify Toxoplasma genes that are specifically involved in the environmental resistance and infectivity of sporozoites. Our central hypotheses are that 1) sporozoite-specific micronemal proteins (MICs) are critical for their invasion into host cells; 2) late embryogenesis abundant proteins (LEAs), which are known to provide resistance to environmental stresses such as drought, high salinity, and freezing in a variety of organisms, determine sporozoite resistance to environmental stressors. In our first aim we will determine the role of LEAs in the protection of sporozoites against environmental stressors. In our second aim we will test the hypothesis that MICs that are specifically expressed in sporozoites are involved in the invasion of host cells. The identification of sporozoite genes that play a role in extracellular survival and attachment/invasion of host cells, will pave the way for designing vaccines that can prevent Toxoplasma infection of humans and animals.
项目概要 寄生虫弓形虫可导致免疫功能低下的患者和胎儿患严重疾病, 是美国食源性死亡的第二大原因。摄入卵囊后开始感染 猫的粪便或摄入被组织囊肿污染的肉后。卵囊在体内极其稳定 环境,对大多数灭活程序具有抵抗力,并且具有高度传染性。因为牲畜得到 被源自卵囊的子孢子感染,基于子孢子或子孢子蛋白的疫苗可以是 能有效保护牲畜和人类。目前,唯一可用的疫苗是减毒活疫苗 仅批准用于绵羊。然而,这种疫苗作为疫苗的遗传基础存在严重缺陷。 衰减未知,存在返原风险,生产后需立即使用 因为它是基于活的速殖子,而这种速殖子不能在宿主细胞外长期存活。尽管是批评者 作为弓形虫传播的一步,卵囊内的子孢子尚未得到充分研究,主要是因为它们不 体外可培养,体内难以获得。因此,迫切需要鉴定子孢子基因 对于其入侵宿主细胞至关重要的产品,这可能导致疫苗靶点的发现。 此外,如果知道子孢子极端环境抵抗力的遗传基础,那么它可能 有可能利用这一点使其他弓形虫生命阶段,例如速殖子或其他病原体更容易 在细胞外具有活性,这可以延长基于活寄生虫的疫苗的保质期。我们的整体 目标是确定专门参与环境抗性和抗性的弓形虫基因 子孢子的传染性。我们的中心假设是 1) 子孢子特异性微线蛋白 (MIC) 对于它们侵入宿主细胞至关重要; 2) 晚期胚胎发生丰富蛋白(LEAs),这是已知的 提供对干旱、高盐度和冰冻等环境胁迫的抵抗力 生物体,决定子孢子对环境压力的抵抗力。在我们的第一个目标中,我们将确定 LEA 在保护子孢子免受环境压力方面的作用。在我们的第二个目标中,我们将测试 假设子孢子中特异性表达的 MIC 参与宿主细胞的侵袭。 鉴定在宿主细胞外存活和附着/入侵中发挥作用的子孢子基因 细胞,将为设计预防人类和动物弓形虫感染的疫苗铺平道路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEROEN SAEIJ其他文献

JEROEN SAEIJ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEROEN SAEIJ', 18)}}的其他基金

Genetic barcoding to track Toxoplasma cyst heterogeneity during brain colonization, reactivation, and drug treatment.
基因条形码可追踪脑部定植、重新激活和药物治疗过程中弓形虫囊肿的异质性。
  • 批准号:
    10545368
  • 财政年份:
    2022
  • 资助金额:
    $ 18.97万
  • 项目类别:
Genetic barcoding to track Toxoplasma cyst heterogeneity during brain colonization, reactivation, and drug treatment.
基因条形码可追踪弓形虫包囊在脑定植、重新激活和药物治疗过程中的异质性。
  • 批准号:
    10664008
  • 财政年份:
    2022
  • 资助金额:
    $ 18.97万
  • 项目类别:
Toxoplasma sporozoite genes that determine environmental resistance and invasion of host cells.
弓形虫子孢子基因决定宿主细胞的环境抵抗力和入侵。
  • 批准号:
    10507659
  • 财政年份:
    2022
  • 资助金额:
    $ 18.97万
  • 项目类别:
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
对营养敏感的弓形虫菌株进行合成致死性筛选,以鉴定介导慢性弓形虫感染中营养获取的新蛋白质。
  • 批准号:
    10010286
  • 财政年份:
    2020
  • 资助金额:
    $ 18.97万
  • 项目类别:
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
对营养敏感的弓形虫菌株进行合成致死性筛选,以鉴定介导慢性弓形虫感染中营养获取的新蛋白质。
  • 批准号:
    10097993
  • 财政年份:
    2020
  • 资助金额:
    $ 18.97万
  • 项目类别:
Identification of Toxoplasma genes that mediate its colonization of the eye
鉴定介导其在眼睛定植的弓形虫基因
  • 批准号:
    10242167
  • 财政年份:
    2020
  • 资助金额:
    $ 18.97万
  • 项目类别:
Identification of Toxoplasma genes that mediate its colonization of the eye
鉴定介导其在眼睛定植的弓形虫基因
  • 批准号:
    10040382
  • 财政年份:
    2020
  • 资助金额:
    $ 18.97万
  • 项目类别:
A serological test to determine strains associated with ocular toxoplasmosis
确定与眼弓形体病相关菌株的血清学测试
  • 批准号:
    8891026
  • 财政年份:
    2015
  • 资助金额:
    $ 18.97万
  • 项目类别:
A serological test to determine strains associated with occular toxoplasmosis
确定与眼弓形体病相关菌株的血清学测试
  • 批准号:
    9070589
  • 财政年份:
    2015
  • 资助金额:
    $ 18.97万
  • 项目类别:
Toxoplasma proteins that modulate the host cell
调节宿主细胞的弓形虫蛋白
  • 批准号:
    8880721
  • 财政年份:
    2009
  • 资助金额:
    $ 18.97万
  • 项目类别:

相似国自然基金

基于mRNA甲基转移酶缺陷的麻疹-腮腺炎联合重组载体疫苗安全性与免疫原性研究
  • 批准号:
    81901679
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于HA蛋白定点偶联M2e的广谱流感疫苗的研究
  • 批准号:
    31800771
  • 批准年份:
    2018
  • 资助金额:
    27.0 万元
  • 项目类别:
    青年科学基金项目
仿生矿化法提高基因Ⅶ型新城疫活疫苗热稳定性及免疫原性的研究
  • 批准号:
    31700801
  • 批准年份:
    2017
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
携带神经特异MicroRNA靶序列的重组寨卡减毒株的设计与免疫保护机制研究
  • 批准号:
    31770995
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
杀鱼爱德华氏菌侵染宿主上皮细胞分子机制研究及靶向侵染关键基因的减毒疫苗设计
  • 批准号:
    31672696
  • 批准年份:
    2016
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

A novel c-di-AMP-based recombinant BCG vaccine
一种新型基于 c-di-AMP 的重组卡介苗疫苗
  • 批准号:
    10667007
  • 财政年份:
    2023
  • 资助金额:
    $ 18.97万
  • 项目类别:
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
  • 批准号:
    10821572
  • 财政年份:
    2023
  • 资助金额:
    $ 18.97万
  • 项目类别:
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
I 型干扰素信号传导损害抗疟原虫 T 细胞记忆
  • 批准号:
    10735305
  • 财政年份:
    2023
  • 资助金额:
    $ 18.97万
  • 项目类别:
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
直肠沙眼衣原体感染对无直肠筛查指征的女性免疫和泌尿生殖感染事件的影响
  • 批准号:
    10703789
  • 财政年份:
    2023
  • 资助金额:
    $ 18.97万
  • 项目类别:
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
确定针对儿童 HIV 感染中预防结核病而优化的持久 BCG 疫苗策略的免疫原性和功效
  • 批准号:
    10760444
  • 财政年份:
    2023
  • 资助金额:
    $ 18.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了